002223 鱼跃医疗
午间休市 12-20 11:30:00
资讯
新帖
简况
鱼跃医疗：当前人们的健康管理意识和要求持续提高，健康监测设备也正在朝着更加多样、实用与便捷的方向发展
证券之星 · 12-13
鱼跃医疗：当前人们的健康管理意识和要求持续提高，健康监测设备也正在朝着更加多样、实用与便捷的方向发展
鱼跃医疗：未来若有相关计划公司会及时履行相应的审议程序及信息披露义务
证券之星 · 12-08
鱼跃医疗：未来若有相关计划公司会及时履行相应的审议程序及信息披露义务
鱼跃医疗获得实用新型专利授权：“一种医疗设备用操作组件”
证券之星 · 12-06
鱼跃医疗获得实用新型专利授权：“一种医疗设备用操作组件”
鱼跃医疗获得实用新型专利授权：“一种防漏液的可拆卸网式雾化器”
证券之星 · 12-03
鱼跃医疗获得实用新型专利授权：“一种防漏液的可拆卸网式雾化器”
鱼跃医疗获得实用新型专利授权：“一种可拆卸网式雾化器的自动挡水结构”
证券之星 · 12-03
鱼跃医疗获得实用新型专利授权：“一种可拆卸网式雾化器的自动挡水结构”
鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序Android手机版软件V1.0.0.0》项目的软件著作权
证券之星 · 11-29
鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序Android手机版软件V1.0.0.0》项目的软件著作权
鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序iOS手机版软件V1.0.0.0》项目的软件著作权
证券之星 · 11-22
鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序iOS手机版软件V1.0.0.0》项目的软件著作权
鱼跃医疗获得实用新型专利授权：“患者呼吸接口”
证券之星 · 11-16
鱼跃医疗获得实用新型专利授权：“患者呼吸接口”
太平洋：给予鱼跃医疗买入评级
证券之星 · 11-06
太平洋：给予鱼跃医疗买入评级
华源证券：给予鱼跃医疗买入评级
证券之星 · 10-30
华源证券：给予鱼跃医疗买入评级
东吴证券：给予鱼跃医疗买入评级
证券之星 · 10-30
东吴证券：给予鱼跃医疗买入评级
【机构调研记录】财通基金调研鱼跃医疗、三生国健等4只个股（附名单）
证券之星 · 10-29
【机构调研记录】财通基金调研鱼跃医疗、三生国健等4只个股（附名单）
【机构调研记录】湘财基金调研鱼跃医疗、吉比特
证券之星 · 10-29
【机构调研记录】湘财基金调研鱼跃医疗、吉比特
【机构调研记录】泓德基金调研晶盛机电、鱼跃医疗等15只个股（附名单）
证券之星 · 10-29
【机构调研记录】泓德基金调研晶盛机电、鱼跃医疗等15只个股（附名单）
【机构调研记录】泉果基金调研鱼跃医疗、合合信息等9只个股（附名单）
证券之星 · 10-29
【机构调研记录】泉果基金调研鱼跃医疗、合合信息等9只个股（附名单）
鱼跃医疗：有知名机构彤源投资，盘京投资，高毅资产参与的多家机构于10月26日调研我司
证券之星 · 10-28
鱼跃医疗：有知名机构彤源投资，盘京投资，高毅资产参与的多家机构于10月26日调研我司
鱼跃医疗：对明年血糖业务的发展充满信心
美港电讯 · 10-28
鱼跃医疗：对明年血糖业务的发展充满信心
国金证券：给予鱼跃医疗买入评级
证券之星 · 10-26
国金证券：给予鱼跃医疗买入评级
图解鱼跃医疗三季报：第三季度单季净利润同比减40.95%
证券之星 · 10-26
图解鱼跃医疗三季报：第三季度单季净利润同比减40.95%
鱼跃医疗(002223.SZ)发布前三季度业绩，净利润15.32亿元，同比下降30.09%
智通财经 · 10-25
鱼跃医疗(002223.SZ)发布前三季度业绩，净利润15.32亿元，同比下降30.09%
加载更多
公司概况
公司名称：
江苏鱼跃医疗设备股份有限公司
所属行业：
专用设备制造业
上市日期：
2008-04-18
主营业务：
江苏鱼跃医疗设备股份有限公司的主营业务是研发、制造和销售医疗器械产品及提供相关解决方案。公司产品主要集中在呼吸制氧、糖尿病护理、感染控制解决方案、家用类电子检测及体外诊断、急救与临床及康复器械等业务领域。公司目前拥有“鱼跃yuwell”、“洁芙柔”、“华佗Hwato”、“金钟JZ”、“安尔碘”、“普美康PRIMEDIC”、“六六视觉”等几大主要品牌。“鱼跃”品牌深入人心，依托鱼跃产品力的不断提升及有效的品牌传播，以及旗下产品在海内外医疗一线的卓越表现，公司品牌价值和品牌优势显著提升。
发行价格：
9.48
{"stockData":{"symbol":"002223","market":"SZ","secType":"STK","nameCN":"鱼跃医疗","latestPrice":36.4,"timestamp":1734670674000,"preClose":35.97,"halted":0,"volume":6284598,"delay":0,"floatShares":939000000,"shares":1002000000,"eps":1.7325,"marketStatus":"午间休市","marketStatusCode":3,"change":0.43,"latestTime":"12-20 11:30:00","open":35.97,"high":36.69,"low":35.52,"amount":228000000,"amplitude":0.0325,"askPrice":36.44,"askSize":7,"bidPrice":36.4,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.7325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734670800000},"adr":0,"adjPreClose":35.97,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":39.57,"lowLimit":32.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1002476929,"pbRate":2.88,"roa":"--","roe":"12.54%","epsLYR":2.41,"committee":-0.803738,"marketValue":36490000000,"floatMarketCap":34168000000,"peRate":21.010102,"changeRate":0.012,"turnoverRate":0.0067,"status":0},"requestUrl":"/m/hq/s/002223","defaultTab":"news","newsList":[{"id":"2491098376","title":"鱼跃医疗：当前人们的健康管理意识和要求持续提高，健康监测设备也正在朝着更加多样、实用与便捷的方向发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2491098376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491098376?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:00","pubTimestamp":1734102014,"startTime":"0","endTime":"0","summary":"证券之星消息，鱼跃医疗12月13日在投资者关系平台上答复投资者关心的问题。当前人们的健康管理意识和要求持续提高，健康监测设备也正在朝着更加多样、实用与便捷的方向发展。未来公司会继续密切关注前沿技术的发展与应用，持续提升产品性能与用户体验，在相应业务领域内为用户提供良好的增值服务，谢谢。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300048731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0114","BK0185","BK0251","BK0188","002223","BK0146","BK0197"],"gpt_icon":0},{"id":"2489880317","title":"鱼跃医疗：未来若有相关计划公司会及时履行相应的审议程序及信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2489880317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489880317?lang=zh_cn&edition=full","pubTime":"2024-12-08 14:00","pubTimestamp":1733637632,"startTime":"0","endTime":"0","summary":"证券之星消息，鱼跃医疗12月08日在投资者关系平台上答复投资者关心的问题。投资者：董秘您好，请问公司2022年的应交税费达到3.11亿元人民币，而2022年之前的应交税费均低于一亿元，请问是什么原因导致了如此大的增幅？以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120800001030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","BK0188","BK0070","BK0197","002223","BK0251","BK0185"],"gpt_icon":0},{"id":"2489986495","title":"鱼跃医疗获得实用新型专利授权：“一种医疗设备用操作组件”","url":"https://stock-news.laohu8.com/highlight/detail?id=2489986495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489986495?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:10","pubTimestamp":1733422224,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项实用新型专利授权，专利名为“一种医疗设备用操作组件”，专利申请号为CN202323661247.1，授权日为2024年12月6日。今年以来鱼跃医疗新获得专利授权80个，较去年同期减少了3.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600001835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0197","BK0251","002223","BK0188","BK0146","BK0185","BK0070","159873"],"gpt_icon":0},{"id":"2488025546","title":"鱼跃医疗获得实用新型专利授权：“一种防漏液的可拆卸网式雾化器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2488025546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488025546?lang=zh_cn&edition=full","pubTime":"2024-12-03 02:22","pubTimestamp":1733163740,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项实用新型专利授权，专利名为“一种防漏液的可拆卸网式雾化器”，专利申请号为CN202323642830.8，授权日为2024年12月3日。本实用新型在出液通道内设置防漏液装置，当更换雾化装置时，堵头可在弹簧的作用下封堵出口，解决了网式雾化器更换雾化装置的漏水问题。今年以来鱼跃医疗新获得专利授权78个，较去年同期增加了4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300002939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","BK0197","BK0185","BK0251","002223","BK0114","BK0146"],"gpt_icon":0},{"id":"2488602342","title":"鱼跃医疗获得实用新型专利授权：“一种可拆卸网式雾化器的自动挡水结构”","url":"https://stock-news.laohu8.com/highlight/detail?id=2488602342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488602342?lang=zh_cn&edition=full","pubTime":"2024-12-03 02:22","pubTimestamp":1733163734,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项实用新型专利授权，专利名为“一种可拆卸网式雾化器的自动挡水结构”，专利申请号为CN202323659480.6，授权日为2024年12月3日。今年以来鱼跃医疗新获得专利授权78个，较去年同期增加了4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300002902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","002223","BK0114","BK0197","BK0146","BK0185","BK0188","BK0251"],"gpt_icon":0},{"id":"2487346230","title":"鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序Android手机版软件V1.0.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2487346230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487346230?lang=zh_cn&edition=full","pubTime":"2024-11-29 01:18","pubTimestamp":1732814290,"startTime":"0","endTime":"0","summary":"证券之星消息，近日鱼跃医疗（002223）新注册了《鱼跃医疗便携式呼吸机移动应用程序Android手机版软件V1.0.0.0》项目的软件著作权。今年以来鱼跃医疗新注册软件著作权4个，较去年同期减少了20%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.7亿元，同比减1.48%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900000385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002223","BK0197","BK0251","BK0070","BK0146","BK0185","BK0188"],"gpt_icon":0},{"id":"2485103014","title":"鱼跃医疗新注册《鱼跃医疗便携式呼吸机移动应用程序iOS手机版软件V1.0.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485103014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485103014?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:18","pubTimestamp":1732209491,"startTime":"0","endTime":"0","summary":"证券之星消息，近日鱼跃医疗（002223）新注册了《鱼跃医疗便携式呼吸机移动应用程序iOS手机版软件V1.0.0.0》项目的软件著作权。今年以来鱼跃医疗新注册软件著作权3个，较去年同期减少了40%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.7亿元，同比减1.48%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200000751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0114","BK0185","BK0251","BK0188","002223","BK0146","BK0197"],"gpt_icon":0},{"id":"2483823695","title":"鱼跃医疗获得实用新型专利授权：“患者呼吸接口”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483823695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483823695?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:41","pubTimestamp":1731699696,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项实用新型专利授权，专利名为“患者呼吸接口”，专利申请号为CN202323621254.9，授权日为2024年11月1日。今年以来鱼跃医疗新获得专利授权73个，较去年同期减少了2.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600009286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0114","BK0185","BK0251","BK0188","002223","BK0146","BK0197"],"gpt_icon":0},{"id":"2481648612","title":"太平洋：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481648612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481648612?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:45","pubTimestamp":1730871918,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚近期对鱼跃医疗进行研究并发布了研究报告《鱼跃医疗点评报告：第三季度营收同比增速回正，新一代CGM销售实现快速拓展》，本报告对鱼跃医疗给出买入评级，当前股价为36.6元。此外，公司在2023年第二、第三季度分别产生了2.55亿、2.87亿资产处置收益。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有19家机构给出评级，买入评级16家，增持评级3家；过去90天内机构目标均价为42.1。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600019335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223","601099"],"gpt_icon":0},{"id":"2479141592","title":"华源证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479141592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479141592?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:57","pubTimestamp":1730260651,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对鱼跃医疗进行研究并发布了研究报告《Q3收入增速改善，费用投入有所增加》，本报告对鱼跃医疗给出买入评级，当前股价为33.67元。 鱼跃医疗 投资要点： 事件：鱼跃医疗公布2024年三季度业绩。2020年后通过创新重塑，聚焦三大高成长赛道，增长潜力大，维持公司“买入”评级。最新盈利预测明细如下：该股最近90天内共有18家机构给出评级，买入评级15家，增持评级3家；过去90天内机构目标均价为42.1。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000019730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002223"],"gpt_icon":0},{"id":"2479298710","title":"东吴证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479298710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479298710?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:06","pubTimestamp":1730246817,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对鱼跃医疗进行研究并发布了研究报告《2024三季报点评：单季度收入转正，长期看好老龄化赛道优质标的》，本报告对鱼跃医疗给出买入评级，当前股价为33.98元。 去年同期资产处置收益影响，公司净利率回落正常区间。最新盈利预测明细如下：该股最近90天内共有18家机构给出评级，买入评级15家，增持评级3家；过去90天内机构目标均价为42.1。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223","601555"],"gpt_icon":0},{"id":"2479982214","title":"【机构调研记录】财通基金调研鱼跃医疗、三生国健等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479982214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479982214?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:05","pubTimestamp":1730160333,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，财通基金近期对4家上市公司进行了调研，相关名单如下：1）鱼跃医疗 个股亮点：公司国内最大康复护理和医用供氧系列医疗器械专业生产企业；公司参股10%苏州苏州医云健康，后者主要从事互联网健康管理服务、智能硬件的研发及互联网药品交易等业务。旗下最近一年表现最佳的公募基金产品为财通福佑定开混合发起，最新单位净值为1.55，近一年增长62.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","BK0070","BK0185","BK0197","BK0239","002223","BK0188","688336","BK0114"],"gpt_icon":0},{"id":"2479498217","title":"【机构调研记录】湘财基金调研鱼跃医疗、吉比特","url":"https://stock-news.laohu8.com/highlight/detail?id=2479498217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479498217?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:05","pubTimestamp":1730160320,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，湘财基金近期对2家上市公司进行了调研，相关名单如下：1）鱼跃医疗 个股亮点：公司国内最大康复护理和医用供氧系列医疗器械专业生产企业；公司参股10%苏州苏州医云健康，后者主要从事互联网健康管理服务、智能硬件的研发及互联网药品交易等业务。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0094","BK0188","BK0197","BK0114","603444","BK0217","BK0070","SG9999006597.SGD","002223","BK0251","BK0146","IE0005HP3H50.USD","BK0185"],"gpt_icon":0},{"id":"2479498229","title":"【机构调研记录】泓德基金调研晶盛机电、鱼跃医疗等15只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479498229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479498229?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:04","pubTimestamp":1730160286,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，泓德基金近期对15家上市公司进行了调研，相关名单如下：1）晶盛机电 个股亮点：公司是国内单晶炉龙头企业；公司的单晶炉市占率超80%，在手订单近百亿；公司晶体实验室经过半年多的工艺测试，全自动MPCVD法生长金刚石设备成功生长出高品质宝石级的金刚石晶体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002223","BK0125","BK0197","BK0251","LU1655091616.SGD","300316","BK0054","BK0070","BK0146","BK0185","BK0064","BK0188"],"gpt_icon":0},{"id":"2479498414","title":"【机构调研记录】泉果基金调研鱼跃医疗、合合信息等9只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2479498414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479498414?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:04","pubTimestamp":1730160282,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，泉果基金近期对9家上市公司进行了调研，相关名单如下：1）鱼跃医疗 个股亮点：公司国内最大康复护理和医用供氧系列医疗器械专业生产企业；公司参股10%苏州苏州医云健康，后者主要从事互联网健康管理服务、智能硬件的研发及互联网药品交易等业务。旗下最近一年表现最佳的公募基金产品为泉果思源三年持有期混合A，最新单位净值为0.96，近一年增长7.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0070","688615","BK0231","BK0146","BK0188","BK0114","BK0185","002223","BK0251"],"gpt_icon":0},{"id":"2478214588","title":"鱼跃医疗：有知名机构彤源投资，盘京投资，高毅资产参与的多家机构于10月26日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2478214588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478214588?lang=zh_cn&edition=full","pubTime":"2024-10-28 10:53","pubTimestamp":1730084014,"startTime":"0","endTime":"0","summary":"公司认为CGM 产品具有较大的市场空间与发展潜力，且相关市场预计将呈现稳定增长态势。一方面，相关技术的进步和产量的增加，将有效降低生产成本，促使 CGM 产品的价格更加普惠，从而促进市场需求和销售量增长；另一方面，随着 CGM 产品品质的不断提升，如何将其与胰岛素产品有效联动，以及通过软件应用以实现更优的糖尿病管理，将成为行业发展的重点方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800007255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","BK0185","BK0070","BK0197","002223","BK0188","BK0114"],"gpt_icon":0},{"id":"2478119518","title":"鱼跃医疗：对明年血糖业务的发展充满信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2478119518","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478119518?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:05","pubTimestamp":1730077551,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4007","BK0070","BK0185","BK0188","002223","BK0114","BK0197","BK0146","BK0251","BGM"],"gpt_icon":0},{"id":"2478924896","title":"国金证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478924896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478924896?lang=zh_cn&edition=full","pubTime":"2024-10-26 20:55","pubTimestamp":1729947321,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维,何冠洲近期对鱼跃医疗进行研究并发布了研究报告《三季度收入回归正增长，营销投入显著提升》，本报告对鱼跃医疗给出买入评级，当前股价为34.9元。CGM产品在国内上市后销售实现快速拓展，同时新一代产品研发工作也在稳步推进中。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级14家，增持评级3家；过去90天内机构目标均价为40.93。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600009284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223"],"gpt_icon":0},{"id":"2478951603","title":"图解鱼跃医疗三季报：第三季度单季净利润同比减40.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478951603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478951603?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:48","pubTimestamp":1729874902,"startTime":"0","endTime":"0","summary":"证券之星消息，鱼跃医疗2024年三季报显示，公司主营收入60.28亿元，同比下降9.53%；归母净利润15.32亿元，同比下降30.09%；扣非净利润12.74亿元，同比下降23.74%；其中2024年第三季度，公司单季度主营收入17.2亿元，同比上升2.21%；单季度归母净利润4.11亿元，同比下降40.95%；单季度扣非净利润3.1亿元，同比下降25.38%；负债率18.26%，投资收益2150.23万元，财务费用-1.31亿元，毛利率50.13%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600000548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223"],"gpt_icon":0},{"id":"2478936603","title":"鱼跃医疗(002223.SZ)发布前三季度业绩，净利润15.32亿元，同比下降30.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478936603","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478936603?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:09","pubTimestamp":1729865384,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鱼跃医疗(002223.SZ)发布2024年三季度报告，前三季度，公司实现营业收入60.28亿元，同比下降9.53%。归属于上市公司股东的净利润15.32亿元，同比下降30.09%。归属于上市公司股东的扣除非经常性损益的净利润12.74亿元，同比下降23.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002223"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2008-04-18","address":"江苏省镇江市丹阳市开发区百胜路1号","stockEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0047},{"period":"3month","weight":0.1726},{"period":"6month","weight":-0.0418},{"period":"1year","weight":0.1083},{"period":"ytd","weight":0.0734}],"companyName":"江苏鱼跃医疗设备股份有限公司","boardCode":"AI0035","perCapita":"0股","boardName":"专用设备制造业","registeredCapital":"100247万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 江苏鱼跃医疗设备股份有限公司的主营业务是研发、制造和销售医疗器械产品及提供相关解决方案。公司产品主要集中在呼吸制氧、糖尿病护理、感染控制解决方案、家用类电子检测及体外诊断、急救与临床及康复器械等业务领域。公司目前拥有“鱼跃yuwell”、“洁芙柔”、“华佗Hwato”、“金钟JZ”、“安尔碘”、“普美康PRIMEDIC”、“六六视觉”等几大主要品牌。“鱼跃”品牌深入人心，依托鱼跃产品力的不断提升及有效的品牌传播，以及旗下产品在海内外医疗一线的卓越表现，公司品牌价值和品牌优势显著提升。","serverTime":1734670685685,"listedPrice":9.48,"stockholders":"40000人(较上一季度增加0.00%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鱼跃医疗(002223)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鱼跃医疗(002223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鱼跃医疗,002223,鱼跃医疗股票,鱼跃医疗股票老虎,鱼跃医疗股票老虎国际,鱼跃医疗行情,鱼跃医疗股票行情,鱼跃医疗股价,鱼跃医疗股市,鱼跃医疗股票价格,鱼跃医疗股票交易,鱼跃医疗股票购买,鱼跃医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鱼跃医疗(002223)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鱼跃医疗(002223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}